Regulation of and by the Myc Oncoprotein
Myc 癌蛋白的调节和调节
基本信息
- 批准号:6922090
- 负责人:
- 金额:$ 29.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-15 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Myc oncoprotein network modulates cell cycle progression, growth, differentiation, apoptosis, and genomic integrity. De-regulation of c-Myc, the prototype member of the family, occurs commonly in many malignancies and is invariably associated with genomic instability and secondary mutations. Understanding the molecular basis for c-Myc's activities will involve characterizing proteins with which it interacts, characterizing the gene products under its control, and determining their roles in mediating c-Myc's multiple phenotypes. Toward the first of these ends, we have recently identified a novel protein, PAG, or peroxiredoxin 1, that interacts with the transcriptional activation domain of c-Myc. PAG inhibits transformation by c-Myc while preserving or even enhancing its other activities. PAG protects cells against oxidative DNA damage and is a tumor suppressor. We have also identified a new transcriptional target for c-Myc, termed MT-MC1, whose over-expression mimics many of the phenotypic properties of c-Myc, including the ability to transform, to alter cellular morphology, to promote apoptosis, to inhibit differentiation, to promote genomic instability, and to regulate some c-Myc target genes. Many of MT-MC1's properties are c-Myc-independent. MT-MC1 thus plays a critical and proximal role in the c-Myc signaling pathway by virtue of its ability to regulate multiple c-Myc functions. Recent evidence also suggests a functional and biochemical connection among c-Myc, PAG, and MT-MC1 with regard to their ability to modulate the response of cells to oxidative stress. Damaged DNA arising from such stress may be a major contributor to tumor generation and/or evolution. In the First Specific Aim of this application, we propose further studies with PAG. These include defining its c-Myc-independent functions, identifying novel proteins with which it interacts, defining the regions necessary for its interaction with c- Myc, and further characterizing a PAG knockout mouse strain. These mice will be used in conjunction with a novel inducible in vivo model of c-Myc-mediated tumorigenesis, regression, and spontaneous recurrence (Tet-Myc mice). In the Second Specific Aim, we propose further studies with MT-MC1. We will examine the effect of MT-MC1 in primary cells, will identify novel MT-MC1-interacting proteins, will further investigate the modular nature of MT-MC1's multiple functions, and will create a conditional MT-MC1 "knockout" mouse strain. Crosses between these animals and either PAG-/- mice or Tet-Myc mice will help to further define in vivo the proposed three-way connection among c-Myc, PAG, and MT-MC1.
描述(由申请人提供):Myc癌蛋白网络调节细胞周期进程、生长、分化、凋亡和基因组完整性。c-Myc家族的原型成员c-Myc的失调通常发生在许多恶性肿瘤中,并且总是与基因组不稳定性和继发性突变相关。了解c-Myc活性的分子基础将涉及表征与其相互作用的蛋白质,表征其控制下的基因产物,并确定它们在介导c-Myc多种表型中的作用。朝向这些目的的第一个,我们最近已经确定了一种新的蛋白质,PAG,或peroxiredoxin 1,与c-Myc的转录激活结构域相互作用。PAG抑制c-Myc的转化,同时保持甚至增强其其他活性。PAG保护细胞免受氧化DNA损伤,是一种肿瘤抑制剂。我们还确定了一个新的转录c-Myc的目标,称为MT-MC 1,其过表达模仿许多c-Myc的表型特性,包括转化的能力,改变细胞形态,促进细胞凋亡,抑制分化,促进基因组不稳定性,并调节一些c-Myc靶基因。MT-MC 1的许多特性是不依赖于c-Myc的。因此,MT-MC 1凭借其调节多种c-Myc功能的能力在c-Myc信号传导途径中起关键和近端作用。最近的证据还表明,c-Myc,PAG和MT-MC 1之间的功能和生物化学联系,关于它们调节细胞对氧化应激的反应的能力。由这种应激引起的受损DNA可能是肿瘤产生和/或演变的主要贡献者。在本申请的第一个具体目标中,我们建议使用PAG进行进一步研究。这些包括定义其c-Myc-独立的功能,鉴定与其相互作用的新蛋白,定义其与c-Myc相互作用所必需的区域,以及进一步表征PAG敲除小鼠品系。这些小鼠将与c-Myc介导的肿瘤发生、消退和自发复发的新型可诱导体内模型(Tet-Myc小鼠)结合使用。在第二个具体目标中,我们建议对MT-MC 1进行进一步研究。我们将研究MT-MC 1在原代细胞中的作用,将确定新的MT-MC 1相互作用蛋白,将进一步研究MT-MC 1的多种功能的模块化性质,并将创建一个有条件的MT-MC 1“敲除”小鼠品系。这些动物与PAG-/-小鼠或Tet-Myc小鼠之间的杂交将有助于进一步在体内定义c-Myc、PAG和MT-MC 1之间的拟议三向连接。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward Victor Prochownik其他文献
Edward Victor Prochownik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward Victor Prochownik', 18)}}的其他基金
Control of Metabolism and Energy-Sensing Pathways by c-Myc
c-Myc 对代谢和能量传感途径的控制
- 批准号:
8629267 - 财政年份:2014
- 资助金额:
$ 29.42万 - 项目类别:
Control of Metabolism and Energy-Sensing Pathways by c-Myc
c-Myc 对代谢和能量传感途径的控制
- 批准号:
8876612 - 财政年份:2014
- 资助金额:
$ 29.42万 - 项目类别:
Structure-based design of novel low molecular weight c-Myc inhibitors
基于结构的新型低分子量 c-Myc 抑制剂的设计
- 批准号:
8269082 - 财政年份:2009
- 资助金额:
$ 29.42万 - 项目类别:
Structure-based design of novel low molecular weight c-Myc inhibitors
基于结构的新型低分子量 c-Myc 抑制剂的设计
- 批准号:
8469738 - 财政年份:2009
- 资助金额:
$ 29.42万 - 项目类别:
Structure-based design of novel low molecular weight c-Myc inhibitors
基于结构的新型低分子量 c-Myc 抑制剂的设计
- 批准号:
8118025 - 财政年份:2009
- 资助金额:
$ 29.42万 - 项目类别:
Structure-based design of novel low molecular weight c-Myc inhibitors
基于结构的新型低分子量 c-Myc 抑制剂的设计
- 批准号:
7697691 - 财政年份:2009
- 资助金额:
$ 29.42万 - 项目类别:
相似海外基金
Mechanism of spironolactone-induced Ca2+ increase in rat testicular arteriole smooth muscle cells revealed by real-time laser confocal scanning microscopy.
实时激光共聚焦扫描显微镜揭示螺内酯诱导大鼠睾丸小动脉平滑肌细胞 Ca2+ 增加的机制。
- 批准号:
24590259 - 财政年份:2012
- 资助金额:
$ 29.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CONFOCAL SCANNING MICROSCOPY & HI RESOLUTION SEM OF CEREBELLAR CORTEX
共焦扫描显微镜
- 批准号:
6278494 - 财政年份:1998
- 资助金额:
$ 29.42万 - 项目类别:
CONFOCAL SCANNING MICROSCOPY & HI RESOLUTION SEM OF CEREBELLAR CORTEX
共焦扫描显微镜
- 批准号:
6117299 - 财政年份:1998
- 资助金额:
$ 29.42万 - 项目类别: